Vaccine trial for people at high risk of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This early-phase trial studies a long-peptide vaccine designed for people with certain genetic changes that raise the risk of pancreatic cancer. The goal is to help your immune system recognize and respond to cancer-related changes before cancer develops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in a “high-risk” group (family history or a specific inherited gene mutation)
- You must be having pancreatic surveillance imaging (like MRI/CT/EUS) or have a pancreatic cyst being followed
- You may need proof of your exact genetic test results from a clinical lab (CLIA-certified)
- You must be willing and able to sign consent and follow the study schedule
- Your health tests (blood and other organ checks) must meet the trial’s limits
- If you can get pregnant, you must have a negative pregnancy test and use reliable birth control; breastfeeding or pregnancy is not allowed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial tests a cancer vaccine (ELI-002 7P) for people with pancreatic cancer that hasn't spread to other parts of the body. It may be given alone or with another drug (tislelizumab) that helps the immune system fight cancer. The goal is to see if these treatments can help keep the cancer from coming back after surgery or chemotherapy.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
Hear when a new High-Risk Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.